Amar Maletira
Analyst · Stifel
Thank you, Rick. We remain focused on executing our plan and delivered a solid quarter. Fiscal second quarter revenue of $232.1 million exceeded our guidance revenue range of $212 million to $228 million, with both NSE and OSP exceeding the midpoint of our guidance as a result of better execution. Revenue was up 2.5% year-over-year despite currency headwinds of roughly 3 percentage points. The year-on-year revenue growth was primarily driven by strong performance in our OSP business that offset the slight decline in NSE. Our operating income at $30.5 million grew $11.4 million or 60% year-over-year. Operating margin of 13.1% was up 470 basis points year-over-year and exceeded our guidance of 9.5% to 11.5% as a result of continued strong performance in OSP and solid operating expense management. Our operating expenses were down 5.8% year-over-year, primarily driven by reduction in our G&A expenses and optimization of our R&D spend. Recall, at our September 2014 Analyst Day, adjusted to exclude Lumentum, we set a net $40 million annualized OpEx savings target by FY '17. This savings target was measured related to fiscal Q1 2015 annualized OpEx run rate. I'm pleased to report that we executed well on the unlocked plans and have delivered significant portion of the targeted savings as reflected in our first half fiscal 2016 operating expenses. We will continue to execute the remaining expense reduction plans and other savings initiatives during the next several quarters while selectively reinvesting some of the savings in our NSE go-to-market initiatives that are targeted at growth areas such as channels, enterprise and solutions. We delivered earnings per share of $0.11, which also exceeded the high end of our guidance range of $0.06 to $0.08.
Now moving to the results by business segment, starting with NSE. While revenue of $173.3 million declined 1.4% year-over-year, we delivered above the high end of our guidance due to good execution in the NE business, which is our core instrument business. NSE gross margin at 66.4% declined 20 basis points year-over-year due to lower revenue levels. NSE's operating margin of 4.6% exceeded the guidance range of 1% to 3%. Operating margin expanded 350 basis points year-over-year due to solid OpEx management in this business as we continue to focus on optimizing operating expenses to align with revenue. As noted earlier, long term, this should create meaningful operating leverage as we grow the top line in NSE. The Network Enablement or NE business, which is our core instrument business, staged a solid recovery, growing year-on-year for the first time in more than 5 quarters. NE revenue at $136.4 million grew 5.7% from prior year, driven by strength in both wireline field and lab instruments. Our Q2 fiber test field instruments revenue was up double digits sequentially and up high-single digits from our year ago levels, reflecting strength in fiber deployment by our customers. Access field instruments revenue was also up by more than 50% from our year ago levels. However, cable test instruments declined in the same period as customers delayed purchases under the anticipated DOCSIS 3.1 upgrade. This upgrade is expected to occur in the spring. We believe that we are well positioned for this upgrade cycle. Our lab instruments were strong in the quarter in both fiber and optical transport. This is a good leading indicator of continued demand in fiber test field instruments. NE book-to-bill was slightly below 1. We feel comfortable with the order backlog position entering fiscal Q3. NE posted gross margins of 66.4%, an increase of 80 basis points from a year ago, primarily driven by improved operating efficiencies in the supply chain and a favorable mix.
Moving to Service Enablement. SE revenue at $36.9 million declined 21.2% from the prior year period. While the Enterprise business within SE, which is our Network Instruments business, continues to grow, we remain challenged in the assurance business. So legacy assurance portfolio declined at a faster pace compared to the growth in the new opportunities. Revenue in the new growth opportunities within assurance tends to be lumpy due to long sales cycles and timing of customer acceptances of our solutions. In the first half of fiscal 2016, the new growth opportunities within assurance grew double digits year-over-year, but this was offset by the declines in legacy assurance portfolio. In SE, for the first time in 3 quarters, we had a book-to-bill ratio of above 1, and all our deferred revenue and backlog grew year-on-year and sequentially. These are good leading indicators, but we still have a lot of work to do to drive this business for long-term sustainable growth. SE posted gross margins at 66.4%, a decrease of 280 basis points from a year ago due to lower revenue.
Now turning to OSP. Revenue at $58.8 million met the high end of our guidance and grew 16.2% from year-ago levels. The revenue upside was attributed to the anticounterfeiting business, driven by increased banknote reprinting volume as well as the growth in the rest of the business. Gross margins at 55.8% was up 300 basis points year-over-year on higher revenue and better absorption. Operating margin at 38.3% exceeded the high end of the guided range and was up 450 basis points year-over-year. The margin expansion was a result of favorable product mix and operating leverage on higher revenue.
Now turning to the balance sheet. Our total cash and short-term investments' ending balance was $914.5 million, which includes our 19.9% Lumentum equity investment valued at $257.5 million. Operating cash flow was negative $1 million, which included separation-related payments of approximately $15 million. During Q2, we entered into a $40 million accelerated share repurchase program, which was completed in early January. We purchased close to 6.6 million shares with an average cost basis of $6.05. We also announced today that the board has authorized the repurchase of up to 100 million of company's common stock to open market or private transactions within the next 12 months. We plan on being opportunistic here, although the timing of the repurchases and the number of shares repurchased will depend on the business and financial market conditions.
Now turning to our guidance. We expect fiscal third quarter revenue for Viavi to be in the range of $210 million to $226 million, operating margin at 11.7% plus or minus 1%, and EPS to be $0.07 to $0.09. We expect NSE revenue to be $155 million to $167 million, with the operating margin at 2.5%, plus or minus 1%. For NSE, our March quarter is a seasonally weak revenue quarter since it is the start of annual budget cycles for our service providers. Also, it is worth noting that we have seasonally higher expenses in this quarter due to increased payroll and other employee-related taxes and benefit.
For OSP, we expect revenue to be $55 million to $59 million, with operating margins at 37.5%, plus or minus 1%. OSP continues to benefit from some large volume banknote printing demand that is benefiting Q3, which we expect to moderate but still remain healthy in Q4 in the mid-$50 million revenue range. Our tax expense is expected to be in the range of $4.5 million to $5 million. We expect other income and expenses to be a net expense of $1.5 million to $2 million and our share count to be approximately 234.5 million shares, with the lower share count reflecting the recently completed $40 million stock buyback. We recognize that the current macro environment is uncertain, and carrier spending has always been and will remain unpredictable. Overall, we believe we have factored the various macro risk in our guidance and in our internal execution plans.
With that, I will return the call to Rick for some closing commentary.